Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (Q42669877)

4 November 2017

title

Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). (English)

1 reference

4 November 2017

1 reference

4

1 reference

4 November 2017

author name string

Pedro Vieira Magalhães

series ordinal

1

1 reference

4 November 2017

Seetal Dodd

series ordinal

2

1 reference

4 November 2017

Andrew A Nierenberg

series ordinal

3

1 reference

4 November 2017

publication date

26 September 2012

1 reference

Australian and New Zealand Journal of Psychiatry

4 November 2017

published in

1 reference

4 November 2017

volume

46

1 reference

4 November 2017

issue

11

1 reference

4 November 2017

page(s)

1058-1067

1 reference

Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Neuroprogression: pathways to progressive brain changes in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

The elephant on the couch: side-effects of psychotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Setting the stage: from prodrome to treatment resistance in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

The potential utility of a staging model as a course specifier: a bipolar disorder perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Evidence and implications for early intervention in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Statistical procedures for analyzing mental health services data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Staging: a neglected dimension in psychiatric classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Mediators of allostasis and systemic toxicity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Psychosocial Disability in the Course of Bipolar I and II Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Allostatic load in bipolar disorder: implications for pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Clinical implications of a staging model for bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Peripheral biomarkers and illness activity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Mood disorders and allostatic load

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Deinstitutionalization revisited: a 5-year follow-up of a randomized clinical trial of hospital-based rehabilitation versus specialized assertive intervention (OPUS) versus standard treatment for patients with first-episode schizophrenia spectrum di

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Mechanisms of illness progression in the recurrent affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Clinical staging: a new scenario for the treatment of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

A clinical monitoring form for mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Effectiveness of adjunctive antidepressant treatment for bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Longitudinal course of bipolar I disorder: duration of mood episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Outcome definitions and predictors in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Staging bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

The impact of staging bipolar disorder on treatment outcome of family psychoeducation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

When illness does not get better: do we need a palliative psychiatry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

Are we missing opportunities for early intervention in bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867412460593

21 January 2018

Identifiers

DOI

10.1177/0004867412460593

1 reference

4 November 2017

1 reference